Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Total Liabilities (2016 - 2026)

Phibro Animal Health has reported Total Liabilities over the past 13 years, most recently at $1.1 billion for Q4 2025.

  • For Q4 2025, Total Liabilities rose 3.32% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, up 3.32%, while the annual FY2025 figure was $1.1 billion, 48.19% up from the prior year.
  • Total Liabilities for Q4 2025 was $1.1 billion at Phibro Animal Health, roughly flat from $1.1 billion in the prior quarter.
  • Over five years, Total Liabilities peaked at $1.1 billion in Q2 2025 and troughed at $589.1 million in Q1 2021.
  • A 5-year average of $766.6 million and a median of $693.3 million in 2022 define the central range for Total Liabilities.
  • Biggest five-year swings in Total Liabilities: increased 0.85% in 2023 and later surged 51.72% in 2025.
  • Year by year, Total Liabilities stood at $609.7 million in 2021, then grew by 13.75% to $693.5 million in 2022, then rose by 1.22% to $701.9 million in 2023, then surged by 47.98% to $1.0 billion in 2024, then grew by 3.32% to $1.1 billion in 2025.
  • Business Quant data shows Total Liabilities for PAHC at $1.1 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.1 billion in Q2 2025.